Market Overview:
The global prostacyclin drug market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of PAH, rising geriatric population, and technological advancements in the field of prostacyclin drugs. Based on type, the global prostacyclin drug market is segmented into epoprostenol sodium, treprostinil, iloprost, and beraprost sodium. Epoprostenol sodium dominates this market owing to its high efficacy and safety profile as compared to other types of prostacyclins available in the market. Based on application, this market is segmented into for injection use, for oral use (tablets or capsules), and for inhalation use (nebulizers). Injection usage dominates this application segment due to ease-of-use and higher efficacy as compared to oral or inhalation usage routes.
Product Definition:
Prostacyclin is a type of hormone that helps to keep the blood vessels open and functioning properly. It is used to treat conditions such as high blood pressure, heart failure, and other problems with the heart and blood vessels.
Epoprostenol Sodium:
Epoprostenol sodium is a prostacyclin analog used to treat conditions associated with the cardiovascular and respiratory systems. It works by relaxing constricted blood vessels, which allows more blood flow through them and helps restore normal function.
Treprostinil:
Treprostinil is a prostacyclin analog. Prostacyclins are drugs that help reduce inflammation by acting as powerful natural anti-inflammatory agents. They act by blocking the action of cytokines, which are substances that cause inflammation. Cytokines are proteins produced in response to injury or infection and can have either positive or negative effects on the body depending on their type and location in the body.
Application Insights:
The market is segmented by application into for injection, for oral and for inhalation. For injection was the largest application segment in 2017 owing to its wide usage as a blood thinner and anti-inflammatory agent. The growing geriatric population prone to cardiovascular diseases will be one of the key factors driving this demand over the forecast period.
For oral is expected to be one of the fastest-growing segments during the forecast period on account of increasing product utilization in clinical trials as an antioxidant and neuroprotective agent. In addition, it has been found that this compound possesses strong antidiabetic properties which may lead to increased consumption during future years.
Regional Analysis:
North America dominated the global prostacyclin drug market in 2017. The presence of well-established healthcare facilities and highly developed healthcare infrastructure is one of the major factors responsible for its large share. In addition, a high prevalence of chronic diseases such as cardiovascular disorders, respiratory diseases, and diabetes is also expected to drive the demand for PTC drugs in this region. According to data published by CDC’s National Center for Health Statistics (NCHS), around 29% population aged 6 years and above was suffering from some form of disability related to vision, hearing or speech in 2016.
Growth Factors:
- Increasing incidence of pulmonary arterial hypertension (PAH)
- Growing awareness about the benefits of prostacyclin therapy for PAH patients
- Rising demand for better and more effective treatment options for PAH patients
- Availability of novel prostacyclin drugs with improved efficacy and safety profiles
- Growing number of clinical studies evaluating the potential benefits of prostacyclin therapy in various patient populations
Scope Of The Report
Report Attributes
Report Details
Report Title
Prostacyclin Drug Market Research Report
By Type
Epoprostenol Sodium, Treprostinil, Iloprost, Beraprost Sodium
By Application
For Injection, For Oral, For Inhalation
By Companies
United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma, Bayer AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Prostacyclin Drug Market Report Segments:
The global Prostacyclin Drug market is segmented on the basis of:
Types
Epoprostenol Sodium, Treprostinil, Iloprost, Beraprost Sodium
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
For Injection, For Oral, For Inhalation
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- United Therapeutics
- Actelion (J & J)
- GSK
- Teva
- Toray
- Tide Pharma
- Bayer AG
Highlights of The Prostacyclin Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Epoprostenol Sodium
- Treprostinil
- Iloprost
- Beraprost Sodium
- By Application:
- For Injection
- For Oral
- For Inhalation
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prostacyclin Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Prostacyclin is a medication that is used to treat heart disease and other conditions. It works by reducing the amount of blood flow in the vessels of the body.
Some of the key players operating in the prostacyclin drug market are United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma, Bayer AG.
The prostacyclin drug market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Prostacyclin Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Prostacyclin Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Prostacyclin Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Prostacyclin Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Prostacyclin Drug Market Size & Forecast, 2020-2028
4.5.1 Prostacyclin Drug Market Size and Y-o-Y Growth
4.5.2 Prostacyclin Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Epoprostenol Sodium
5.2.2 Treprostinil
5.2.3 Iloprost
5.2.4 Beraprost Sodium
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 For Injection
6.2.2 For Oral
6.2.3 For Inhalation
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Prostacyclin Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Prostacyclin Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Epoprostenol Sodium
9.6.2 Treprostinil
9.6.3 Iloprost
9.6.4 Beraprost Sodium
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 For Injection
9.10.2 For Oral
9.10.3 For Inhalation
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Epoprostenol Sodium
10.6.2 Treprostinil
10.6.3 Iloprost
10.6.4 Beraprost Sodium
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 For Injection
10.10.2 For Oral
10.10.3 For Inhalation
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Epoprostenol Sodium
11.6.2 Treprostinil
11.6.3 Iloprost
11.6.4 Beraprost Sodium
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 For Injection
11.10.2 For Oral
11.10.3 For Inhalation
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Epoprostenol Sodium
12.6.2 Treprostinil
12.6.3 Iloprost
12.6.4 Beraprost Sodium
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 For Injection
12.10.2 For Oral
12.10.3 For Inhalation
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Epoprostenol Sodium
13.6.2 Treprostinil
13.6.3 Iloprost
13.6.4 Beraprost Sodium
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 For Injection
13.10.2 For Oral
13.10.3 For Inhalation
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Prostacyclin Drug Market: Competitive Dashboard
14.2 Global Prostacyclin Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 United Therapeutics
14.3.2 Actelion (J & J)
14.3.3 GSK
14.3.4 Teva
14.3.5 Toray
14.3.6 Tide Pharma
14.3.7 Bayer AG
